Global Diabetic Footwear Market Overview

Global Diabetic Footwear Market was valued at USD 7.14 Billion in 2021 and is expected to reach USD 11.32 Billion by the year 2028, at a CAGR of 6.8%.

Diabetes is a chronic (long-lasting) health condition that affects the body's mechanism of turning food into energy. Most of the food is broken down into sugar (also called glucose) and released into the bloodstream. When blood sugar goes up, it signals the pancreas to release insulin. Insulin is a key that allows blood sugar to enter the cells of the body, to convert it into energy. In diabetic patients there is not enough secretion of insulin or the body cells stop responding to insulin thus, increasing the amount of glucose in the bloodstream. A diabetic foot ulcer (DFU) is an open sore or wound that affects about 15% of diabetic individuals and is most typically found on the bottom of the foot. 6% of people who get a foot ulcer will end up in the hospital owing to infection or another ulcer-related problem. Anyone who has diabetes can develop DFU however, people who take insulin are more prone to develop DFU, as are patients with diabetes-related heart, kidney, and eye diseases. Obesity, as well as the consumption of alcohol and tobacco, contribute to the development of foot ulcers. The growing number of diabetic individuals across the globe is propelling the growth of the diabetic footwear market.

Market Dynamics and Key Factors in Diabetic Footwear:

Drivers

Diabetic footwear or therapeutic footwear are specifically designed for the diabetic population to minimize the risk of developing various skin diseases related to diabetes in the feet region. One way to keep diabetic feet safe is to reduce the amount of shock (vertical pressure) and shear (horizontal friction) they experience. Diabetic footwear is specifically designed to help decrease these stresses. Diabetic footwear helps in controlling the range of motion in certain joints in the foot, as it can reduce inflammation, relieve discomfort, and create a more stable and functional foot. Moreover, ulceration can occur when there is too much pressure in a concentrated location (skin breakdown). Diabetic footwear aids in the natural redistribution of forces, reducing the risk of complications. Diabetic footwear offers numerous health benefits thus, supporting the growth of the market over the analysis period.

Diabetic footwear also helps in promoting blood circulation in the feet region. The increase in the number of diabetic individuals has stimulated manufacturers to design footwear in many stylish designs, from dressy to athletic to Velcro to more traditional ones. Thus, the availability of numerous choices is promoting the usage of diabetic footwear among individuals. According to IDF, in 2021, 537 million individuals in the age group 20-79 are living with diabetes. This number is expected to rise to 784 million (1 in 8 adults) by 2045. This growing number of diabetic patients is expected to strengthen the expansion of the diabetic footwear market over the forecasted period.

Restraints:

Even though the number of people suffering from diabetes is on the rise, most of them are undiagnosed. People are unaware of the serious complications that arise due to diabetes. Most of the diabetic population lives in low-middle income countries, and in these regions, people don't pay attention to ulcers and other diabetes-related diseases. Moreover, the cost of diabetic footwear is high thereby, restricting the reach of these innovative products to wealthy individuals only. In addition, the growing local competition is expected to limit the business of global prominent players thus, restraining the growth of the market in the forecast period.

Opportunities:

According to IDF, diabetes was responsible for an estimated USD 966 billion in global health expenditure in 2021. This represents a 316% increase over the last 15 years. People in developed, as well as developing regions, are spending more on medications and on other supplementary products to limit the side effects of diabetes. Most of the individuals suffering from diabetes are from developing regions. For instance, in India 80 million individuals are estimated to have diabetes. In the western pacific region (China, Australia, Japan, Indonesia, Korea, Malaysia, Thailand), 206 million have diabetes. Additionally, in the Middle East & African region, 97 million individuals are suffering from diabetes. This large number of individuals from untapped countries can be targeted by market players to increase their sales. Furthermore, governments across the world are striving hard to provide medical assistance for their underprivileged citizens thus, creating opportunities for the market players.

Market Segmentation For Diabetic Footwear

By type, the shoe segment is expected to generate the highest revenue from the diabetic footwear market. A high degree of customer demand for several types of casual medical footwear and the growing sports trends are the main factors driving the growth of the segment. A good diabetic shoe gives not only comfort but also protection. Diabetic shoes help to prevent ulcers, foot strains, and calluses. To avoid irritation caused by materials rubbing against the foot as one moves, the interior is composed of comfortable seam-free fabrics with no stitching. A big toe-box is provided in diabetic shoes to allow extra room for the toes, which is especially significant when considering abnormalities like bunions or hammertoes.

By end-user, the men segment is precited to contribute more than the women segment in the projected timeframe. Men are more likely than women to be diagnosed with diabetes, according to the Centers for Disease Control and Prevention (CDC). Men have more visceral fat (mostly abdominal) than women. Visceral fat is more metabolically active than subcutaneous fat, which means it produces hormones that can have an impact on a person's health. A higher risk of metabolic syndrome, including type 2 diabetes, is significantly connected with more visceral fat thereby, supporting the growth of the segments.

By distribution channel, the offline segment is projected to have the lion's share of the diabetic footwear market. The well-developed retail infrastructure in developed as well as developing regions in promoting individuals to buy diabetic footwear from specialty stores. Offline buying of shoes eliminates the buying of counterfeit products as well individuals can try out several options before buying the right pair. Furthermore, the expanding number of pharmacies around the world that offer diabetic shoes is boosting the growth of the segment.

Players Covered in Diabetic Footwear market are :

  • Advanced Diabetic Solutions (US)
  • Alkem Laboratories Ltd (India)
  • Etonic Worldwide LLC (US)
  • Aetrex Worldwide Inc. (the US)
  • Orthofeet Inc. (the US)
  • Dr. Comfort LLC (US)
  • Dr. Zen Inc. (the US)
  • DARCO International Inc. (US)
  • Drew Shoe Corporation (US)
  • Apex Foot Health Industries LLC (US)
  • Podartis Srl (Italy) and other major players.

Regional Analysis of Diabetic Footwear Market:

The diabetic footwear market in the Asia-Pacific region is anticipated to develop at the highest CAGR over the analysis period attributed to the rapid explosion in the number of diabetic individuals. China, India, Pakistan, and Indonesia are the prominent countries having the largest number of diabetic patients respectively. Governments of the respective regions have launched several national programs to control the spread of diabetes. For instance, the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) was launched by the Indian government in 2010, to strengthen the infrastructure, human resource development, and promote good health hygiene. The government also circulated measures to avoid diabetic foot problems, similar initiatives by other economies in this region are expected to support the growth of the market in this region.

The North American region is forecasted to have the highest share of the diabetic footwear market attributed to the rising incidences of DFU in this region. Economies in this region are highly developed and the per capita spending in this region is also high. Diabetic patients in this region are more concerned about their feet health thus, willingly adopt innovative products for the treatment of DFU. It is estimated that in 2021, near about 51 million individuals have diabetes and this number is projected to reach 63 million by 2045. Diabetes is the main cause of nontraumatic lower-extremity amputations in the United States, with an amputation occurring in 14 to 24 percent of diabetic individuals who develop a foot ulcer thus, supporting the expansion of the diabetic footwear market in this region.

The diabetic footwear market in the European region is expected to flourish at a significant growth rate. The population's awareness of health and hygiene, as well as their spending on healthcare products, has resulted in expected sales of diabetic footwear in this region. In addition, the growing sports and leisure trends among the population have stimulated market platers to design innovative diabetic footwear for their customers. Soon, it is projected that the availability of products with advanced, excellent foot comfort characteristics will continue to be a positive factor for the development of the diabetic footwear market in this region.

Recent Industry Developments in Diabetic Footwear Market:

  • In January 2022, Alkem Laboratories Ltd announced the launch of patented technology for the treatment of Diabetic Foot Ulcer (DFU) for its customers in India. The solution will be based on cutting-edge 4D Bioprinting technology and will be used to treat deep, non-healing chronic wounds. It is scheduled to enter the Indian market in the second half of 2022, following regulatory approval.
  • In December 2021, DARCO International, Inc. and Sensoria® Health have announced a collaboration to produce smart diabetic footwear that is powered by mobile and cloud patient monitoring technology. Sensoria's industry-leading remote patient monitoring software and Sensoria® Core hardware solutions will be integrated with DARCO's world-class podiatry products in this new partnership.

COVID-19 Impact on Diabetic Footwear Market:

The outbreak of COVID-19 put an unprecedented challenge on the healthcare system, and it was under tremendous pressure during the first and second waves. It mobilized the medical resources of most developed countries due to its contagiousness, mortality, and emerging nature. Many government-imposed population containment to contain and control the disease's progression. Other diseases, particularly chronic ones, have not, however, disappeared. The management of diabetic foot ulcers (DFUs) during the COVID-19 pandemic represented a logistical and therapeutic challenge. The mechanism of COVID-19, with its cytokine storm and hypercoagulability in the inflammatory and ischemic context of DFU, was concerning, thus urging patients to exercise caution. The usage of high dosages of corticosteroids in diabetic patients with infected feet is especially concerning. As a result, COVID-19 sparked a surge in telemedicine and home care. The demand for diabetic footwear increased during the pandemic time attributed to the rise in home care facilities. This footwear helped patients to prevent serious complications that arise due to diabetes. To summarize, the demand for diabetic footwear has increased owing to the rapid spread of COVID-19.

Global Diabetic Footwear Market

Base Year:

2021

Forecast Period:

2022-2028

Historical Data:

2016 to 2020

Market Size in 2021:

USD 7.14 Bn.

Forecast Period 2022-28 CAGR:

6.8%

Market Size in 2028:

USD 11.32 Bn.

Segments Covered:

By Type

  • Shoes
  • Sandals
  • Slippers

By  End User

  • Men
  • Women

By Distribution Channel

  • Online
  • Offline

By Region

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Increasing Number of Diabetic Patients

Key Market Restraints:

  • Unawareness Among The People

Key Opportunities:

  • Governments Across the World are Working to Provide Medical Assistance for Underprivileged Citizens

Companies Covered in the report:

  • Advanced Diabetic Solutions (US), Alkem Laboratories Ltd (India), Etonic Worldwide LLC (US), Aetrex Worldwide Inc. (the US), Orthofeet Inc. (the US), and Other Major Players

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By End User
 3.3 By Distribution Channel

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Diabetic Footwear Market by Type
 5.1 Diabetic Footwear Market Overview Snapshot and Growth Engine
 5.2 Diabetic Footwear Market Overview
 5.3 Shoes
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Shoes: Grographic Segmentation
 5.4 Sandals
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Sandals: Grographic Segmentation
 5.5 Slippers
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Slippers: Grographic Segmentation

Chapter 6: Diabetic Footwear Market by End User
 6.1 Diabetic Footwear Market Overview Snapshot and Growth Engine
 6.2 Diabetic Footwear Market Overview
 6.3 Men
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Men: Grographic Segmentation
 6.4 Women
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Women: Grographic Segmentation

Chapter 7: Diabetic Footwear Market by Distribution Channel
 7.1 Diabetic Footwear Market Overview Snapshot and Growth Engine
 7.2 Diabetic Footwear Market Overview
 7.3 Online
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Online: Grographic Segmentation
 7.4 Offline
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Offline: Grographic Segmentation

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Positioning
  8.1.2 Diabetic Footwear Sales and Market Share By Players
  8.1.3 Industry BCG Matrix
  8.1.4 Ansoff Matrix
  8.1.5 Diabetic Footwear Industry Concentration Ratio (CR5 and HHI)
  8.1.6 Top 5 Diabetic Footwear Players Market Share
  8.1.7 Mergers and Acquisitions
  8.1.8 Business Strategies By Top Players
 8.2 ADVANCED DIABETIC SOLUTIONS
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Operating Business Segments
  8.2.5 Product Portfolio
  8.2.6 Business Performance
  8.2.7 Key Strategic Moves and Recent Developments
  8.2.8 SWOT Analysis
 8.3 ALKEM LABORATORIES LTD
 8.4 ETONIC WORLDWIDE LLC
 8.5 AETREX WORLDWIDE INC.
 8.6 ORTHOFEET INC.
 8.7 DR. COMFORT LLC
 8.8 DR. ZEN INC.
 8.9 DARCO INTERNATIONAL INC.
 8.10 DREW SHOE CORPORATION
 8.11 APEX FOOT HEALTH INDUSTRIES LLC
 8.12 PODARTIS SRL
 8.13 OTHER MAJOR PLAYERS

Chapter 9: Global Diabetic Footwear Market Analysis, Insights and Forecast, 2016-2028
 9.1 Market Overview
 9.2 Historic and Forecasted Market Size By Type
  9.2.1 Shoes
  9.2.2 Sandals
  9.2.3 Slippers
 9.3 Historic and Forecasted Market Size By End User
  9.3.1 Men
  9.3.2 Women
 9.4 Historic and Forecasted Market Size By Distribution Channel
  9.4.1 Online
  9.4.2 Offline

Chapter 10: North America Diabetic Footwear Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 Shoes
  10.4.2 Sandals
  10.4.3 Slippers
 10.5 Historic and Forecasted Market Size By End User
  10.5.1 Men
  10.5.2 Women
 10.6 Historic and Forecasted Market Size By Distribution Channel
  10.6.1 Online
  10.6.2 Offline
 10.7 Historic and Forecast Market Size by Country
  10.7.1 U.S.
  10.7.2 Canada
  10.7.3 Mexico

Chapter 11: Europe Diabetic Footwear Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Shoes
  11.4.2 Sandals
  11.4.3 Slippers
 11.5 Historic and Forecasted Market Size By End User
  11.5.1 Men
  11.5.2 Women
 11.6 Historic and Forecasted Market Size By Distribution Channel
  11.6.1 Online
  11.6.2 Offline
 11.7 Historic and Forecast Market Size by Country
  11.7.1 Germany
  11.7.2 U.K.
  11.7.3 France
  11.7.4 Italy
  11.7.5 Russia
  11.7.6 Spain
  11.7.7 Rest of Europe

Chapter 12: Asia-Pacific Diabetic Footwear Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Shoes
  12.4.2 Sandals
  12.4.3 Slippers
 12.5 Historic and Forecasted Market Size By End User
  12.5.1 Men
  12.5.2 Women
 12.6 Historic and Forecasted Market Size By Distribution Channel
  12.6.1 Online
  12.6.2 Offline
 12.7 Historic and Forecast Market Size by Country
  12.7.1 China
  12.7.2 India
  12.7.3 Japan
  12.7.4 Singapore
  12.7.5 Australia
  12.7.6 New Zealand
  12.7.7 Rest of APAC

Chapter 13: Middle East & Africa Diabetic Footwear Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 Shoes
  13.4.2 Sandals
  13.4.3 Slippers
 13.5 Historic and Forecasted Market Size By End User
  13.5.1 Men
  13.5.2 Women
 13.6 Historic and Forecasted Market Size By Distribution Channel
  13.6.1 Online
  13.6.2 Offline
 13.7 Historic and Forecast Market Size by Country
  13.7.1 Turkey
  13.7.2 Saudi Arabia
  13.7.3 Iran
  13.7.4 UAE
  13.7.5 Africa
  13.7.6 Rest of MEA

Chapter 14: South America Diabetic Footwear Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Type
  14.4.1 Shoes
  14.4.2 Sandals
  14.4.3 Slippers
 14.5 Historic and Forecasted Market Size By End User
  14.5.1 Men
  14.5.2 Women
 14.6 Historic and Forecasted Market Size By Distribution Channel
  14.6.1 Online
  14.6.2 Offline
 14.7 Historic and Forecast Market Size by Country
  14.7.1 Brazil
  14.7.2 Argentina
  14.7.3 Rest of SA

Chapter 15 Investment Analysis

Chapter 16 Analyst Viewpoint and Conclusion

Global Diabetic Footwear Market

Base Year:

2021

Forecast Period:

2022-2028

Historical Data:

2016 to 2020

Market Size in 2021:

USD 7.14 Bn.

Forecast Period 2022-28 CAGR:

6.8%

Market Size in 2028:

USD 11.32 Bn.

Segments Covered:

By Type

  • Shoes
  • Sandals
  • Slippers

By  End User

  • Men
  • Women

By Distribution Channel

  • Online
  • Offline

By Region

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
  • Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
  • South America (Brazil, Argentina, Rest of SA)

Key Market Drivers:

  • Increasing Number of Diabetic Patients

Key Market Restraints:

  • Unawareness Among The People

Key Opportunities:

  • Governments Across the World are Working to Provide Medical Assistance for Underprivileged Citizens

Companies Covered in the report:

  • Advanced Diabetic Solutions (US), Alkem Laboratories Ltd (India), Etonic Worldwide LLC (US), Aetrex Worldwide Inc. (the US), Orthofeet Inc. (the US), and Other Major Players

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. DIABETIC FOOTWEAR MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. DIABETIC FOOTWEAR MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. DIABETIC FOOTWEAR MARKET COMPETITIVE RIVALRY
TABLE 005. DIABETIC FOOTWEAR MARKET THREAT OF NEW ENTRANTS
TABLE 006. DIABETIC FOOTWEAR MARKET THREAT OF SUBSTITUTES
TABLE 007. DIABETIC FOOTWEAR MARKET BY TYPE
TABLE 008. SHOES MARKET OVERVIEW (2016-2028)
TABLE 009. SANDALS MARKET OVERVIEW (2016-2028)
TABLE 010. SLIPPERS MARKET OVERVIEW (2016-2028)
TABLE 011. DIABETIC FOOTWEAR MARKET BY END USER
TABLE 012. MEN MARKET OVERVIEW (2016-2028)
TABLE 013. WOMEN MARKET OVERVIEW (2016-2028)
TABLE 014. DIABETIC FOOTWEAR MARKET BY DISTRIBUTION CHANNEL
TABLE 015. ONLINE MARKET OVERVIEW (2016-2028)
TABLE 016. OFFLINE MARKET OVERVIEW (2016-2028)
TABLE 017. NORTH AMERICA DIABETIC FOOTWEAR MARKET, BY TYPE (2016-2028)
TABLE 018. NORTH AMERICA DIABETIC FOOTWEAR MARKET, BY END USER (2016-2028)
TABLE 019. NORTH AMERICA DIABETIC FOOTWEAR MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 020. N DIABETIC FOOTWEAR MARKET, BY COUNTRY (2016-2028)
TABLE 021. EUROPE DIABETIC FOOTWEAR MARKET, BY TYPE (2016-2028)
TABLE 022. EUROPE DIABETIC FOOTWEAR MARKET, BY END USER (2016-2028)
TABLE 023. EUROPE DIABETIC FOOTWEAR MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 024. DIABETIC FOOTWEAR MARKET, BY COUNTRY (2016-2028)
TABLE 025. ASIA PACIFIC DIABETIC FOOTWEAR MARKET, BY TYPE (2016-2028)
TABLE 026. ASIA PACIFIC DIABETIC FOOTWEAR MARKET, BY END USER (2016-2028)
TABLE 027. ASIA PACIFIC DIABETIC FOOTWEAR MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 028. DIABETIC FOOTWEAR MARKET, BY COUNTRY (2016-2028)
TABLE 029. MIDDLE EAST & AFRICA DIABETIC FOOTWEAR MARKET, BY TYPE (2016-2028)
TABLE 030. MIDDLE EAST & AFRICA DIABETIC FOOTWEAR MARKET, BY END USER (2016-2028)
TABLE 031. MIDDLE EAST & AFRICA DIABETIC FOOTWEAR MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 032. DIABETIC FOOTWEAR MARKET, BY COUNTRY (2016-2028)
TABLE 033. SOUTH AMERICA DIABETIC FOOTWEAR MARKET, BY TYPE (2016-2028)
TABLE 034. SOUTH AMERICA DIABETIC FOOTWEAR MARKET, BY END USER (2016-2028)
TABLE 035. SOUTH AMERICA DIABETIC FOOTWEAR MARKET, BY DISTRIBUTION CHANNEL (2016-2028)
TABLE 036. DIABETIC FOOTWEAR MARKET, BY COUNTRY (2016-2028)
TABLE 037. ADVANCED DIABETIC SOLUTIONS: SNAPSHOT
TABLE 038. ADVANCED DIABETIC SOLUTIONS: BUSINESS PERFORMANCE
TABLE 039. ADVANCED DIABETIC SOLUTIONS: PRODUCT PORTFOLIO
TABLE 040. ADVANCED DIABETIC SOLUTIONS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 040. ALKEM LABORATORIES LTD: SNAPSHOT
TABLE 041. ALKEM LABORATORIES LTD: BUSINESS PERFORMANCE
TABLE 042. ALKEM LABORATORIES LTD: PRODUCT PORTFOLIO
TABLE 043. ALKEM LABORATORIES LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 043. ETONIC WORLDWIDE LLC: SNAPSHOT
TABLE 044. ETONIC WORLDWIDE LLC: BUSINESS PERFORMANCE
TABLE 045. ETONIC WORLDWIDE LLC: PRODUCT PORTFOLIO
TABLE 046. ETONIC WORLDWIDE LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 046. AETREX WORLDWIDE INC.: SNAPSHOT
TABLE 047. AETREX WORLDWIDE INC.: BUSINESS PERFORMANCE
TABLE 048. AETREX WORLDWIDE INC.: PRODUCT PORTFOLIO
TABLE 049. AETREX WORLDWIDE INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 049. ORTHOFEET INC.: SNAPSHOT
TABLE 050. ORTHOFEET INC.: BUSINESS PERFORMANCE
TABLE 051. ORTHOFEET INC.: PRODUCT PORTFOLIO
TABLE 052. ORTHOFEET INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 052. DR. COMFORT LLC: SNAPSHOT
TABLE 053. DR. COMFORT LLC: BUSINESS PERFORMANCE
TABLE 054. DR. COMFORT LLC: PRODUCT PORTFOLIO
TABLE 055. DR. COMFORT LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 055. DR. ZEN INC.: SNAPSHOT
TABLE 056. DR. ZEN INC.: BUSINESS PERFORMANCE
TABLE 057. DR. ZEN INC.: PRODUCT PORTFOLIO
TABLE 058. DR. ZEN INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 058. DARCO INTERNATIONAL INC.: SNAPSHOT
TABLE 059. DARCO INTERNATIONAL INC.: BUSINESS PERFORMANCE
TABLE 060. DARCO INTERNATIONAL INC.: PRODUCT PORTFOLIO
TABLE 061. DARCO INTERNATIONAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 061. DREW SHOE CORPORATION: SNAPSHOT
TABLE 062. DREW SHOE CORPORATION: BUSINESS PERFORMANCE
TABLE 063. DREW SHOE CORPORATION: PRODUCT PORTFOLIO
TABLE 064. DREW SHOE CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 064. APEX FOOT HEALTH INDUSTRIES LLC: SNAPSHOT
TABLE 065. APEX FOOT HEALTH INDUSTRIES LLC: BUSINESS PERFORMANCE
TABLE 066. APEX FOOT HEALTH INDUSTRIES LLC: PRODUCT PORTFOLIO
TABLE 067. APEX FOOT HEALTH INDUSTRIES LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 067. PODARTIS SRL: SNAPSHOT
TABLE 068. PODARTIS SRL: BUSINESS PERFORMANCE
TABLE 069. PODARTIS SRL: PRODUCT PORTFOLIO
TABLE 070. PODARTIS SRL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 070. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 071. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 072. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 073. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. DIABETIC FOOTWEAR MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. DIABETIC FOOTWEAR MARKET OVERVIEW BY TYPE
FIGURE 012. SHOES MARKET OVERVIEW (2016-2028)
FIGURE 013. SANDALS MARKET OVERVIEW (2016-2028)
FIGURE 014. SLIPPERS MARKET OVERVIEW (2016-2028)
FIGURE 015. DIABETIC FOOTWEAR MARKET OVERVIEW BY END USER
FIGURE 016. MEN MARKET OVERVIEW (2016-2028)
FIGURE 017. WOMEN MARKET OVERVIEW (2016-2028)
FIGURE 018. DIABETIC FOOTWEAR MARKET OVERVIEW BY DISTRIBUTION CHANNEL
FIGURE 019. ONLINE MARKET OVERVIEW (2016-2028)
FIGURE 020. OFFLINE MARKET OVERVIEW (2016-2028)
FIGURE 021. NORTH AMERICA DIABETIC FOOTWEAR MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 022. EUROPE DIABETIC FOOTWEAR MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 023. ASIA PACIFIC DIABETIC FOOTWEAR MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 024. MIDDLE EAST & AFRICA DIABETIC FOOTWEAR MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 025. SOUTH AMERICA DIABETIC FOOTWEAR MARKET OVERVIEW BY COUNTRY (2016-2028)

Please Wait...

Frequently Asked Questions :

What would be the forecast period in the Diabetic Footwear Market research report?

The forecast period in the Diabetic Footwear Market research report is 2022-2028.

Who are the key players in Diabetic Footwear Market?

Advanced Diabetic Solutions (US), Alkem Laboratories Ltd (India), Etonic Worldwide LLC (US), Aetrex Worldwide Inc. (the US), Orthofeet Inc. (the US), Dr. Comfort LLC (US), Dr. Zen Inc. (the US), DARCO International Inc. (US), Drew Shoe Corporation (US), Apex Foot Health Industries LLC (US), Podartis Srl (Italy), and Other Major Players.

What are the segments of Diabetic Footwear Market?

Diabetic Footwear Market is segmented into Type, End User, Distribution Channel and region. By Type, the market is categorized into Shoes, Sandals, and Slippers. By End User, the market is categorized into Men, Women. By Distribution Channel, the market is categorized into Online, Offline. By region, it is analysed across North America (U.S.; Canada; Mexico), Europe (Germany; U.K.; France; Italy; Russia; Spain, etc.), Asia-Pacific (China; India; Japan; Southeast Asia, etc.), South America (Brazil; Argentina, etc.), Middle East & Africa (Saudi Arabia; South Africa, etc.).

What is the Diabetic Footwear Market?

Diabetic footwear helps in controlling the range of motion in certain joints in the foot, as it can reduce inflammation, relieve discomfort, and create a more stable and functional foot. Moreover, ulceration can occur when there is too much pressure in a concentrated location.

How big is Diabetic Footwear Market?

Global Diabetic Footwear Market was valued at USD 7.14 Billion in 2021 and is expected to reach USD 11.32 Billion by the year 2028, at a CAGR of 6.8%.